Terumo Corporation (4543.T)
- Previous Close
2,620.00 - Open
2,653.50 - Bid --
- Ask --
- Day's Range
2,625.50 - 2,689.50 - 52 Week Range
1,856.00 - 3,014.50 - Volume
2,909,700 - Avg. Volume
3,816,609 - Market Cap (intraday)
3.979T - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
40.27 - EPS (TTM)
66.55 - Earnings Date May 14, 2024
- Forward Dividend & Yield 22.00 (0.84%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
2,973.80
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
www.terumo.comRecent News: 4543.T
Performance Overview: 4543.T
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4543.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4543.T
Valuation Measures
Market Cap
3.89T
Enterprise Value
3.93T
Trailing P/E
39.39
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.41
Price/Book (mrq)
3.20
Enterprise Value/Revenue
4.45
Enterprise Value/EBITDA
19.05
Financial Highlights
Profitability and Income Statement
Profit Margin
11.19%
Return on Assets (ttm)
5.09%
Return on Equity (ttm)
8.65%
Revenue (ttm)
885.17B
Net Income Avi to Common (ttm)
99.04B
Diluted EPS (ttm)
66.55
Balance Sheet and Cash Flow
Total Cash (mrq)
181.38B
Total Debt/Equity (mrq)
18.60%
Levered Free Cash Flow (ttm)
22.32B
Research Analysis: 4543.T
Company Insights: 4543.T
4543.T does not have Company Insights